RS60172B1 - Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum - Google Patents

Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum

Info

Publication number: RS60172B1
Authority: RS; Serbia
Prior art keywords: pharmaceutical composition; xanthan gum; oral suspension; suspension including; flavonoid fraction
Prior art date: 2012-12-21

Application number

RS20200422A

Other languages

Serbian (sr)

Inventor

Stéphanie Marsas

Jean-Manuel Pean

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2013-12-20

Publication date

2020-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754590&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS60172(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-20 Application filed by Servier Lab filed Critical Servier Lab

2020-05-29 Publication of RS60172B1 publication Critical patent/RS60172B1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

RS20200422A 2012-12-21 2013-12-20 Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum RS60172B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1203579A FR2999934B1 (en)	2012-12-21	2012-12-21	PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION COMPRISING A FLAVONOIC FRACTION AND XANTHAN GUM
EP13198744.8A EP2745839B1 (en)	2012-12-21	2013-12-20	Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum

Publications (1)

Publication Number	Publication Date
RS60172B1 true RS60172B1 (en)	2020-05-29

Family

ID=47754590

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
RS20200422A RS60172B1 (en)	2012-12-21	2013-12-20	Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
RS20240401A RS65369B1 (en)	2012-12-21	2013-12-20	Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction comprising diosmin and xanthan gum

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
RS20240401A RS65369B1 (en)	2012-12-21	2013-12-20	Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction comprising diosmin and xanthan gum

Country Status (42)

Country	Link
EP (2)	EP3669879B1 (en)
KR (1)	KR101595107B1 (en)
CN (2)	CN103877108A (en)
AP (1)	AP2013007323A0 (en)
AR (1)	AR094224A1 (en)
BR (1)	BR102013032405A2 (en)
CH (1)	CH707354B1 (en)
CL (1)	CL2013003588A1 (en)
CO (1)	CO6970124A1 (en)
CR (1)	CR20130652A (en)
CU (1)	CU24209B1 (en)
CY (1)	CY1123021T1 (en)
DK (2)	DK2745839T3 (en)
EA (1)	EA030949B1 (en)
ES (1)	ES2781755T3 (en)
FI (1)	FI3669879T3 (en)
FR (1)	FR2999934B1 (en)
GT (1)	GT201300316A (en)
HK (2)	HK1198934A1 (en)
HR (1)	HRP20200829T1 (en)
HU (1)	HUE048969T2 (en)
JO (1)	JO3688B1 (en)
LT (2)	LT3669879T (en)
MA (1)	MA35600B1 (en)
ME (1)	ME03771B (en)
MX (1)	MX355719B (en)
MY (1)	MY160753A (en)
NI (1)	NI201300144A (en)
PE (1)	PE20141302A1 (en)
PH (1)	PH12013000362B1 (en)
PL (1)	PL2745839T3 (en)
PT (2)	PT3669879T (en)
RO (1)	RO130611A2 (en)
RS (2)	RS60172B1 (en)
RU (1)	RU2582954C2 (en)
SG (1)	SG2013089255A (en)
SI (1)	SI2745839T1 (en)
SV (1)	SV2013004600A (en)
TN (1)	TN2013000505A1 (en)
UA (1)	UA119025C2 (en)
UY (1)	UY35190A (en)
WO (1)	WO2014096740A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101725461B1 (en) *	2015-12-29	2017-04-10	연세대학교 산학협력단	Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Diosmin as Active Ingredients
RU2704976C2 (en) *	2017-05-10	2019-11-01	Общество с ограниченной ответственностью "Трейдсервис"	Phlebotrophic combination pharmaceutical composition
FR3083980B1 (en) *	2018-07-20	2021-04-16	Servier Lab	PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMINE OR A FLAVONOIC FRACTION
WO2021123341A1 (en)	2019-12-20	2021-06-24	Krka, D.D., Novo Mesto	Composition comprising diosmin

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR6967M (en) *	1968-01-22	1969-05-19
FR2661610B1 (en) *	1990-05-02	1994-09-30	Rhone Poulenc Sante	NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
JPH0724560B2 (en)	1990-06-01	1995-03-22	株式会社ヤクルト本社	Beverage containing plant extract
FR2668705A1 (en) *	1990-11-06	1992-05-07	Bouchara Sa	Novel skin preparations having a phlebotonic action and process for preparing them
FR2726469B1 (en) *	1994-11-08	1996-12-13	Adir	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS
FR2748025B1 (en) *	1996-04-25	1998-10-30	Adir	NOVEL DIOSMETINE ACIDS AND ESTERS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP4202439B2 (en) *	1996-10-01	2008-12-24	江崎グリコ株式会社	Flavonoid solubilization method, sugar transfer method and high concentration flavonoid solution
AU730391B2 (en) *	1996-10-10	2001-03-08	Mcneil-Ppc, Inc.	Liquid antacid compositions
FR2781156B1 (en) *	1998-07-20	2001-06-29	Lafon Labor	PHARMACEUTICAL COMPOSITION FOR PARTICULARLY FOR THE PREVENTION AND TREATMENT OF RADIOMUCITES AND CHEMOMUCITES
US20040161435A1 (en) *	2003-02-14	2004-08-19	Gupta Shyam K.	Skin Firming Anti-Aging Cosmetic Mask Compositions
US20040219124A1 (en) *	2003-05-01	2004-11-04	Gupta Shyam K.	Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System
US20080069779A1 (en) *	2003-08-04	2008-03-20	Foamix Ltd.	Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US20070166255A1 (en) *	2004-11-22	2007-07-19	Gupta Shyam K	Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
ITMI20050517A1 (en) *	2005-03-30	2006-09-30	Therapicon Srl	PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
CN100444847C (en) *	2006-01-11	2008-12-24	刘展欣	Micronize diosmin and hesperidine composition suppository
DE102006020382A1 (en) *	2006-04-28	2007-10-31	Henkel Kgaa	Cosmetic oil-in-water emulsion, useful e.g. to treat skin, comprises oil or fat phase comprising a component e.g. branched saturated alkanol, water, a cosmetically active substance e.g. monomer and a polysaccharide
KR20080030835A (en) *	2006-10-02	2008-04-07	쎄라피콘 에스.알.엘.	Pharmaceutical composition
JP2010514790A (en) *	2006-12-28	2010-05-06	リメリックバイオファーマ，インコーポレイテッド	Methods and compositions for therapeutic treatment
US8999395B2 (en) *	2007-02-09	2015-04-07	Ceva Sante Animale	Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
BRPI0821871A2 (en) *	2008-01-03	2015-06-16	Wockhardt Research Center	Oral pharmaceutical suspension comprising acetaminophen and ibuprofen
EP2353596A1 (en) *	2010-02-02	2011-08-10	SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.	Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
US20110223256A1 (en) *	2010-03-11	2011-09-15	Stokely-Van Camp, Inc.	Method For Stabilizing Flavonoid Aqueous Dispersion
US20120070475A1 (en) *	2010-03-11	2012-03-22	Pepsico, Inc	Zero Calorie Polyphenol Aqueous Dispersions

2012
- 2012-12-21 FR FR1203579A patent/FR2999934B1/en active Active
2013
- 2013-12-02 PH PH12013000362A patent/PH12013000362B1/en unknown
- 2013-12-03 SG SG2013089255A patent/SG2013089255A/en unknown
- 2013-12-05 PE PE2013002757A patent/PE20141302A1/en not_active Application Discontinuation
- 2013-12-05 TN TNP2013000505A patent/TN2013000505A1/en unknown
- 2013-12-06 CH CH02023/13A patent/CH707354B1/en unknown
- 2013-12-09 SV SV2013004600A patent/SV2013004600A/en unknown
- 2013-12-09 JO JOP/2013/0355A patent/JO3688B1/en active
- 2013-12-09 MX MX2013014519A patent/MX355719B/en active IP Right Grant
- 2013-12-12 CR CR20130652A patent/CR20130652A/en unknown
- 2013-12-12 UY UY0001035190A patent/UY35190A/en not_active Application Discontinuation
- 2013-12-13 CL CL2013003588A patent/CL2013003588A1/en unknown
- 2013-12-13 CO CO13291852A patent/CO6970124A1/en unknown
- 2013-12-17 MY MYPI2013702456A patent/MY160753A/en unknown
- 2013-12-17 RO ROA201301007A patent/RO130611A2/en unknown
- 2013-12-17 BR BR102013032405-1A patent/BR102013032405A2/en not_active Application Discontinuation
- 2013-12-17 AP AP2013007323A patent/AP2013007323A0/en unknown
- 2013-12-18 CU CUP2013000166A patent/CU24209B1/en active IP Right Grant
- 2013-12-18 UA UAA201314859A patent/UA119025C2/en unknown
- 2013-12-18 MA MA36588A patent/MA35600B1/en unknown
- 2013-12-19 GT GT201300316A patent/GT201300316A/en unknown
- 2013-12-20 AR ARP130104961A patent/AR094224A1/en not_active Application Discontinuation
- 2013-12-20 RS RS20200422A patent/RS60172B1/en unknown
- 2013-12-20 NI NI201300144A patent/NI201300144A/en unknown
- 2013-12-20 LT LTEP19213282.7T patent/LT3669879T/en unknown
- 2013-12-20 DK DK13198744.8T patent/DK2745839T3/en active
- 2013-12-20 ME MEP-2020-73A patent/ME03771B/en unknown
- 2013-12-20 EP EP19213282.7A patent/EP3669879B1/en active Active
- 2013-12-20 PT PT192132827T patent/PT3669879T/en unknown
- 2013-12-20 EP EP13198744.8A patent/EP2745839B1/en active Active
- 2013-12-20 FI FIEP19213282.7T patent/FI3669879T3/en active
- 2013-12-20 SI SI201331727T patent/SI2745839T1/en unknown
- 2013-12-20 CN CN201310711339.8A patent/CN103877108A/en active Pending
- 2013-12-20 KR KR1020130160482A patent/KR101595107B1/en active IP Right Grant
- 2013-12-20 DK DK19213282.7T patent/DK3669879T3/en active
- 2013-12-20 CN CN201810253066.XA patent/CN108392468A/en active Pending
- 2013-12-20 LT LTEP13198744.8T patent/LT2745839T/en unknown
- 2013-12-20 RU RU2013156775/15A patent/RU2582954C2/en active
- 2013-12-20 WO PCT/FR2013/053231 patent/WO2014096740A1/en active Application Filing
- 2013-12-20 EA EA201301300A patent/EA030949B1/en unknown
- 2013-12-20 PT PT131987448T patent/PT2745839T/en unknown
- 2013-12-20 RS RS20240401A patent/RS65369B1/en unknown
- 2013-12-20 PL PL13198744T patent/PL2745839T3/en unknown
- 2013-12-20 HU HUE13198744A patent/HUE048969T2/en unknown
- 2013-12-20 ES ES13198744T patent/ES2781755T3/en active Active
2014
- 2014-12-15 HK HK14112567.2A patent/HK1198934A1/en unknown
- 2014-12-23 HK HK14112848.3A patent/HK1199216A1/en unknown
2020
- 2020-05-21 HR HRP20200829TT patent/HRP20200829T1/en unknown
- 2020-06-04 CY CY20201100502T patent/CY1123021T1/en unknown

Also Published As

Publication number	Publication date
SG2013089255A (en)	2014-07-30
PE20141302A1 (en)	2014-09-26
UA119025C2 (en)	2019-04-25
NI201300144A (en)	2016-01-06
RU2013156775A (en)	2015-06-27
CH707354A1 (en)	2014-06-30
UY35190A (en)	2014-07-31
PL2745839T3 (en)	2020-11-02
FR2999934B1 (en)	2015-02-20
EP3669879B1 (en)	2024-02-28
RS65369B1 (en)	2024-04-30
FR2999934A1 (en)	2014-06-27
EP2745839B1 (en)	2020-03-11
CR20130652A (en)	2014-03-05
ES2781755T3 (en)	2020-09-07
EP2745839A1 (en)	2014-06-25
AP2013007323A0 (en)	2013-12-31
CL2013003588A1 (en)	2014-10-03
CU20130166A7 (en)	2015-08-27
HRP20200829T1 (en)	2020-08-07
KR101595107B1 (en)	2016-02-18
PT2745839T (en)	2020-04-02
BR102013032405A2 (en)	2014-08-26
SV2013004600A (en)	2014-09-19
SI2745839T1 (en)	2020-07-31
CN103877108A (en)	2014-06-25
CU24209B1 (en)	2016-11-29
EA201301300A2 (en)	2014-06-30
PT3669879T (en)	2024-04-04
CN108392468A (en)	2018-08-14
EP3669879A1 (en)	2020-06-24
RO130611A2 (en)	2015-10-30
EA201301300A3 (en)	2014-08-29
PH12013000362A1 (en)	2015-06-22
CO6970124A1 (en)	2014-06-13
RU2582954C2 (en)	2016-04-27
EA030949B1 (en)	2018-10-31
FI3669879T3 (en)	2024-05-20
LT3669879T (en)	2024-03-25
TN2013000505A1 (en)	2015-03-30
HK1198934A1 (en)	2015-06-19
KR20140081738A (en)	2014-07-01
ME03771B (en)	2021-04-20
MA35600B1 (en)	2014-11-01
CY1123021T1 (en)	2021-10-29
PH12013000362B1 (en)	2015-06-22
HUE048969T2 (en)	2020-09-28
MX2013014519A (en)	2014-06-23
CH707354B1 (en)	2017-10-13
DK3669879T3 (en)	2024-04-22
HK1199216A1 (en)	2015-06-26
GT201300316A (en)	2015-05-05
MY160753A (en)	2017-03-15
MX355719B (en)	2018-04-27
JO3688B1 (en)	2020-08-27
AR094224A1 (en)	2015-07-22
WO2014096740A1 (en)	2014-06-26
DK2745839T3 (en)	2020-06-02
LT2745839T (en)	2020-04-10

Publication	Publication Date	Title
HK1205690A1 (en)	2015-12-24	Pharmaceutical composition and administration thereof
IL252566A0 (en)	2017-07-31	Pharmaceutical compositions and methods
IL236024A (en)	2016-09-29	Benzimidazole-proline derivatives and pharmaceutical compositions comprising them
IL236057B (en)	2018-08-30	1,2,4-triazine-6-carboxamide derivatives and pharmaceutical compositions comprising them
HK1203947A1 (en)	2015-11-06	Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions (halofuginol)
SG11201404728VA (en)	2014-09-26	Nanoparticle paste formulations and methods for production and use thereof
HK1199821A1 (en)	2015-07-24	Oral pharmaceutical composition
EP2815753A4 (en)	2015-07-01	Oral pharmaceutical composition
EP2890385A4 (en)	2016-03-23	Topical vitamin d and ubiquinol oral supplement compositions
GB2504390B (en)	2015-06-03	Nutraceutical and pharmaceutical composition
HK1198934A1 (en)	2015-06-19	Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
IL235947A0 (en)	2015-02-01	Solid state isonicotineamide derivatives and pharmaceutical compositions containing them
IL238059A0 (en)	2015-05-31	Pyrolidine derivatives and pharmaceutical compositions containing them
EP2874987A4 (en)	2016-03-16	alpha-AND gamma-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
GB201208315D0 (en)	2012-06-27	Pharmaceutical methods and compositions
IL233983A0 (en)	2014-09-30	Thiazolidinone derivatives and pharmaceutical compositions containing them
IL234614B (en)	2018-02-28	Pharmaceutical composition and preparation method thereof